Vol 6: A systematic review and mixed-treatment comparison of dapagliflozin with existing anti-diabetes treatments for those with type 2 diabetes mellitus inadequately controlled by sulfonylurea monotherapy.Report as inadecuate



 Vol 6: A systematic review and mixed-treatment comparison of dapagliflozin with existing anti-diabetes treatments for those with type 2 diabetes mellitus inadequately controlled by sulfonylurea monotherapy.


Vol 6: A systematic review and mixed-treatment comparison of dapagliflozin with existing anti-diabetes treatments for those with type 2 diabetes mellitus inadequately controlled by sulfonylurea monotherapy. - Download this document for free, or read online. Document in PDF available to download.

Download or read this book online for free in PDF: Vol 6: A systematic review and mixed-treatment comparison of dapagliflozin with existing anti-diabetes treatments for those with type 2 diabetes mellitus inadequately controlled by sulfonylurea monotherapy.
This article is from Diabetology & Metabolic Syndrome, volume 6.AbstractBackground: To compare the first-in-class sodium glucose co-transporter 2 (SGLT2) inhibitor, dapagliflozin, with existing type 2 diabetes mellitus (T2DM) treatment options available within the European Union (EU) for add-on therapy to sulfonylureas (SUs).
Methods: A systematic

Author: Orme, Michelle; Fenici, Peter; Lomon, Isabelle Duprat; Wygant, Gail; Townsend, Rebecca; Roudaut, Marina

Source: https://archive.org/





Related documents